AG
AIA Group’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.7M | Sell |
622,913
-42,665
| -6% | -$3.34M | 1.06% | 16 |
|
|
2025
Q1 | $48.2M | Sell |
665,578
-265,355
| -29% | -$19.2M | 1.18% | 14 |
|
|
2024
Q4 | $68.9M | Buy |
930,933
+181,409
| +24% | +$13.4M | 1.66% | 9 |
|
|
2024
Q3 | $49.5M | Buy |
749,524
+358,556
| +92% | +$23.7M | 1.28% | 17 |
|
|
2024
Q2 | $36.1M | Sell |
390,968
-102,001
| -21% | -$9.42M | 1.06% | 23 |
|
|
2024
Q1 | $47.1M | Sell |
492,969
-108,776
| -18% | -$10.4M | 1.54% | 12 |
|
|
2023
Q4 | $45.9M | Buy |
601,745
+134,452
| +29% | +$10.3M | 1.88% | 10 |
|
|
2023
Q3 | $32.4M | Buy |
467,293
+76,319
| +20% | +$5.29M | 1.58% | 15 |
|
|
2023
Q2 | $36.9M | Sell |
390,974
-72,237
| -16% | -$6.81M | 1.79% | 12 |
|
|
2023
Q1 | $38.3M | Buy |
463,211
+228,272
| +97% | +$18.9M | 2.08% | 12 |
|
|
2022
Q4 | $17.5M | Buy |
234,939
+25,131
| +12% | +$1.88M | 1.07% | 19 |
|
|
2022
Q3 | $17.3M | Buy |
209,808
+196,330
| +1,457% | +$16.2M | 1.14% | 20 |
|
|
2022
Q2 | $1.28M | Sell |
13,478
-3,810
| -22% | -$362K | 0.07% | 124 |
|
|
2022
Q1 | $2.04M | Sell |
17,288
-1,854
| -10% | -$218K | 0.09% | 108 |
|
|
2021
Q4 | $2.48M | Buy |
19,142
+14,582
| +320% | +$1.89M | 0.12% | 85 |
|
|
2021
Q3 | $516K | Buy |
4,560
+762
| +20% | +$86.2K | 0.03% | 166 |
|
|
2021
Q2 | $391K | Buy |
+3,798
| New | +$391K | 0.03% | 158 |
|